Brief by Shorts91 Newsdesk / 07:23pm on 04 Apr 2025,Friday International
India stands to gain from U.S. tariffs imposed under Donald Trump’s administration, as key Indian exports—including pharmaceuticals, chemicals, and metals—are exempt from reciprocal duties. With China facing a 34% tariff on pharmaceuticals, India could emerge as a crucial supplier of affordable medicines. Government officials believe the tariff structure indirectly favors India, allowing it to expand trade into high-tariff markets like Mexico, Canada, and Vietnam. A committee is set to strategize India’s trade response in the coming months. “When it’s dark and gloomy, there is sunshine on the other side,” a senior official remarked on India’s economic prospects. (PC : Reuters)
